We are proactively engaged in educational activities to support the development of children, who will be responsible for the future.
With the aim of increasing children’s interest in science, experiments, and medicines, we have provided travelling science classes for 6th grade students. Our researchers are serving as lecturers and experiment support staff members for all classes in this program, so that children can get to know people who are engaging in research of new medicines. We have carried out this program since FY2015 at Shimamoto Municipal Third Elementary School, which is near the Minase Research Institute, and since FY2019 at Hoei Elementary School, which is near the Joto Pharmaceutical Product Development Center. In FY2022, in response to strong requests by the elementary schools, we conducted detailed infection control measures and were able to provide travelling science classes without any problems. According to comments from children after taking the classes, many of them were surprised by the fact that it takes a long time for new medicines to reach patients and that medicines are packed with various ingenuity. In addition, some children said, "I want to be a researcher in the future." We are pleased that this program may serve as a spark for children to think about their future occupation. This program was also an important experience for our staff members who participated in the program, such as recognizing the importance of connection with the local community and recalling their original intention as researchers by directly experiencing the reactions of children.
|Number of Participants per Year||FY2018||FY2019||FY2020||FY2021||FY2022|
|Lecturers and staff members supporting the experiment||12||25||9||17||24|
|Secretariat staff members||10||22||6||9||8|
After providing travelling science classes, we gave questionnaires to the children, teachers, and our staff members, and are using them to improve this program for the next fiscal year onward.
Following the revision of the Curriculum Guidelines by the Ministry of Education, Culture, Sports, Science and Technology, cancer education has officially started in high schools since FY2022. ONO, as a pharmaceutical company committed to contributing to people's health through the research, development, manufacture, and sale of cancer drugs, has supported initiatives related to cancer education in high schools so that high school students can acquire accurate knowledge of cancer.
We have donated toothbrush/toothpaste sets and toothbrushes manufactured by our company affiliate, BeBrand Medical Dental Co., Ltd., with the aim of contributing to the improvement of children's oral hygiene in light of the fact that good dental health results in an extension of healthy life expectancy. This activity is implemented in line with the June 4th to 10th "Dental and Oral Health Week." In FY2022, we donated 3,601 toothbrush/toothpaste sets and 346 toothbrushes. We cherish the fact that local communities and companies develop together, and we continue to engage in this activity.
|Location||Target||Year started||ONO's related base|
|Mishima-gun, Osaka Prefecture||Elementary schools, kindergartens, day care centers (a total of 17 sites in FY2022)||2014||Minase Research Institute|
|Higashinari-ku, Osaka City||Hoei Elementary School||2018||Joto Pharmaceutical Product Development Center|
We are sponsoring the performance “Kokoro no Gekijo (Theater of the Heart),” which is performed in Kansai and hosted by the Shiki Theater Company / Butai Geijyutsu (Performing Arts) Center. "Theatre of the Heart" is a project to invite children (mainly elementary 6th grade students) from various regions in Japan to theaters free of charge, and demonstrate the excitement of theater, aiming to bring the most important principles for people in life to the children’s hearts, from the basic importance of life, consideration of other people, and the joy of believing in each other, through the performance. In FY2022, due to the impact of COVID-19, the Theater of the Heart was provided through video distribution just like in FY2021.